Axiota Animal Health has filed a notice of an exempt offering of securities to raise $35 Million in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Axiota Animal Health is raising up to $35,000,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Jonathan Lowe played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About Axiota Animal Health
Axiota delivers best-in-class animal health products with proven modes of action that help manage risk and support cattle health, performance, and well-being across all stages of beef and dairy production. The Axiota portfolio includes MULTIMIN 90 and Lactipro. MULTIMIN 90 is a prescription-only injectable trace mineral that provides a supplemental source of zinc, selenium, copper and manganese. Trace minerals are the building blocks of the immune and reproductive systems and MULTIMIN 90 provides sure trace mineral supply by timed injection. Lactipro supplies an immediate, viable population of Mega e a prolific, rumen-native microbe that preferentially consumes lactic acid and produces butyrate. MULTIMIN 90 and Lactipro both prepare cattle to thrive during transition and stress.
To learn more about Axiota Animal Health, visit http://axiota.com/
Contact:
Jonathan Lowe, Chief Executive Officer
317-997-1516
SOURCE: http://www.intelligence360.io
Copyright (c) 2024 SI360 Inc. All rights reserved.